OpenVSafe by OpenVAERS
Search V-safe

JZE-20113-82456

2 vaccinations 1 coded response 14 check-ins 1 free-text entry 1 call case
Sex
Male
Age at first dose
0-4
ZIP prefix
928 / CA
Registered
2022-09-03
Relationship
Child or adolescent in my care
Guardian
CNC-18609-59757
Race
Multiracial
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-09-02
    Dose 1 — Pfizer-BioNTech
  2. 2022-09-03
    Registered in v-safe
  3. 2022-09-03
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · Irritability/crying
    Under 3 check-in
  4. 2022-09-04
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · Irritability/crying
    Under 3 check-in
  5. 2022-09-05
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · Fever · Irritability/crying
    Under 3 check-in
  6. 2022-09-08
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  7. 2022-09-09
    Health check-in — day 7, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  8. 2022-09-16
    Health check-in — day 14, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  9. 2022-09-23
    Health check-in — day 21, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  10. 2022-09-28
    Dose 2 — Pfizer-BioNTech
  11. 2022-10-09
    Health check-in — day 7, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  12. 2022-10-12
    Survey response — day 14, dose 2, under 3
    MedDRA: Respiratory syncytial virus infection — Feeling: Poor · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: RSV infection
    MedDRA releases: 2024-11 · check-in free text available
  13. 2022-10-12
    Report sent to call center — day 14, dose 2, under 3
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  14. 2022-10-13
  15. 2022-10-13
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  16. 2022-10-19
    Health check-in — day 21, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  17. 2022-10-26
    Health check-in — day 28, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  18. 2022-11-02
    Health check-in — day 35, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  19. 2022-11-09
    Health check-in — day 42, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  20. 2023-03-30
    Health check-in — 6 months, dose 2, under 3
    Feeling: Good
    Under 3 check-in

Vaccinations

DoseDateManufacturerCo-administered
12022-09-02Pfizer-BioNTech No
22022-09-28Pfizer-BioNTech No

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 12 (Under 3) — day 14, dose 2, under 3

2022-10-12

Symptoms: RSV infection

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDRespiratory syncytial virus infection · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…